Glucotrol XL Product Description
Glucotrol XL is an oral antihyperglycemic drug from the sulfonylurea group, used in conjunction with diet and exercise for lowering blood glucose level in patients with type 2 diabetes mellitus.
Glucotrol XL lowers blood glucose levels by stimulating release of insulin from the pancreatic cells. The use of antihyperglycemic drug Glucotrol XL may be an alternative treatment in patients, who are unresponsive to other antihyperglycemic agents of sulfonylureas group. The antihyperglycemic drug is prescribed to adolescents aged 18 and older, to adults (including elderly patients) with non-insulin-dependent diabetes mellitus, for the control of hyperglycemia.
The recommended starting dose of Glucotrol XL is 5 mg per day, taken during breakfast. The initial dose for elderly patients or patients with liver disease may be 2.5 mg. Increasing the daily dose of the antihyperglycemic drug is recommended after the glycemic control of the patient. The maximum dose of Glucotrol XL should not exceed 20 mg per day.
If you miss the usual dose of Glucotrol XL, you can take it as soon as you remember, if there is much time left before the next intake of the antihyperglycemic drug. However, if you need to take another dose of Glucotrol XL soon, skip the forgotten dose and return to your recommended regime of medical therapy with Glucotrol XL.
The daily Glucotrol XL dose of 5-10 mg is sufficient for most patients. However, to obtain the desired hypoglycemic effect, some patients may need Glucotrol XL dose, exceeding 20 mg per day.
When Glucotrol XL is prescribed in combination with other blood-glucose-lowering agents, the treatment should be initiated at the lowest recommended dose, and the dose increase of this antihyperglycemic drug should be done based on the clinical assessment of the condition.
Do not store Glucotrol XL in such places, as kitchen or bathroom. Tablets should not be exposed to moisture and heat. The drug Glucotrol XL should be stored at room temperature not exceeding 25°C.
Glucotrol XL Safety Information
Antihyperglycemic drug Glucotrol XL may contribute to serious cardiovascular diseases. Glucotrol XL should be discontinued in first symptoms of heart disorders. Glucotrol XL may cause severe hypoglycemia, so this antihyperglycemic drug is prescribed with caution to older patients and patients with renal insufficiency.
Clinical studies have shown that drugs of the sulfonylureas group (including Glucotrol XL) may cause hemolytic anemia in some patients. In such a case, Glucotrol XL should be discontinued, and an alternative hypoglycemic therapy should be prescribed.
Information on hyperglycemia, published in the review on Glucotrol XL, is distributed and available on an information basis only, and is not a substitute for a consultation of a qualified medical professional. In no event shall the online pharmacy be liable for any incidental or indirect errors, loss, damages and claim, arising from the use of the review materials on the antihyperglycemic drug Glucotrol XL.
Glucotrol XL Side Effects
The frequency of Glucotrol XL side effects is very low. Less than 2% of patients stopped taking Glucotrol XL because of side effects. Keep in mind that aplastic anaemia is possible, when using this drug in combination with other sulphonylureas agents. The most frequent side effects, associated with Glucotrol XL therapy, include hypoglycemia, nervousness, dizziness, flatulence, and tremor. In addition, Glucotrol XL at a dosage, exceeding the recommended one, may provoke diarrhea, abdominal pain, and nausea.